IDO-mediated trp metabolism suppresses antigen-specific T cell immunity and innate immunity in models of allergy, asthma, infection, cancer and autoimmunity31, 32, 33 including EAE15, 16, 17, where natural and synthetic kynurenines modulate antigen-specific T cell responses34. This evidence concerns the gene IDO1 and cancer.